PERCEPTIVE ADVISORS LLC - 31 Mar 2025 SCHEDULE 13G/A Report for Iovance Biotherapeutics, Inc. Common Stock, par value $0.000041666 per share (IOVA)

Filing Manager
PERCEPTIVE ADVISORS LLC
Reporting Manager
Perceptive Advisors LLC
Security
Iovance Biotherapeutics, Inc. Common Stock, par value $0.000041666 per share
Symbol
IOVA
Shares outstanding
337,073,368 shares
Disclosed Ownership
12,808,788 shares
Ownership
3.8%
Form type
SCHEDULE 13G/A
Filing time
15 May 2025, 16:30:04 UTC
Date of event
31 Mar 2025
Previous filing
14 Feb 2025
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"PERCEPTIVE ADVISORS LLC disclosed 3.8% ownership in Iovance Biotherapeutics, Inc. Common Stock, par value $0.000041666 per share (IOVA) on 31 Mar 2025."

Quick Takeaways

  • PERCEPTIVE ADVISORS LLC filed SCHEDULE 13G/A for Iovance Biotherapeutics, Inc. Common Stock, par value $0.000041666 per share (IOVA).
  • Disclosed ownership: 3.8%.
  • Date of event: 31 Mar 2025.

What Changed

  • Previous schedule filing date: 14 Feb 2025.
  • Current filing was accepted on 15 May 2025, 16:30.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Perceptive Advisors LLC 3.8% 12,808,788 0 12,808,788 /s/ Joseph Edelman Joseph Edelman, Managing Member
Joseph Edelman 3.8% 12,808,788 0 12,808,788 /s/ Joseph Edelman Joseph Edelman
Perceptive Life Sciences Master Fund, Ltd. 3.8% 12,808,788 0 12,808,788 /s/ Joseph Edelman Joseph Edelman, Managing Member

Sponsored